Total synthesis and in vitro-antifungal activity of (±)-2- methoxytetradecanoic acid

Archiv der Pharmazie

Volumn 337, Issue 3, 2004, Pages 152-155

  Carballeira, Néstor M ^a   Ortiz, Denisse ^a   Parang, Keykavous ^b   Sardari, Soroush ^b  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

2 Methoxytetradecanoic acid; Antifungal activity; Myristic acid; N Myristoyltransferase

Indexed keywords

2 IODOTETRADECANOIC ACID; 2 METHOXYTETRADECANOIC ACID; ANTIFUNGAL AGENT; DECANOIC ACID; FATTY ACID; METHYL 2 HYDROXYTETRADECANOATE; PROTEIN N MYRISTOYLTRANSFERASE; UNCLASSIFIED DRUG; 2-METHOXYTETRADECANOIC ACID; ACYLTRANSFERASE; AMPHOTERICIN B; GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; MYRISTIC ACID DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; DRUG SYNTHESIS; PRIORITY JOURNAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; SYNTHESIS;

ACYLTRANSFERASES; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; FATTY ACIDS; MYRISTATES; MYRISTIC ACIDS;

EID: 2642553979     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300824     Document Type: Article

References (15)

1. A. Akpan, R. Morgan, Postgrad. Med. J. 2002, 78, 455-459.
2. G. P. Geaney, J. Laryngol Otol. 1967, 81, 987-997.
3. S. Hillier, K. K. Holmes in Sexually Transmitted Diseases (Ed.: K. K. Holmes), McGraw-Hill, New York, NY, 1999, 3rd ed., pp 572-574.
4. T. Mugliston, G. O'Donoghue, J. Laryngol. Otol. 1985, 99, 327-333.
5. P. L. Jr. Fidel, Med. Mycol. 2002, 40, 359-375.
6. H. Gershon, L. Shanks in The Pharmacological Effect of Lipids (Ed.: J. J. Kabara), The American Oil Chemists' Society, Champaign, Illinois, 1978, pp 51-62.
7. N. Mclain, R. Ascanio, C. Baker, R. A. Strohaver, J. W. Dolan, Antimicrob. Agents Chemother. 2000, 44, 2873-2875.
8. T. J. Avis, R. R. Bélanger, Appl. Environ. Microbiol. 2001, 67, 956-960.
9. G. Bergsson, J. Arnfinnsson, O. Steingrímsson, H. Thormar, Antimicrob. Agents Chemother. 2001, 45, 3209-3212.
10. K. Parang, E. E. Knaus, L. I. Wiebe, S. Sardari, M. Daneshtalab, F. Csizmadia, Arch. Pharm. Pharm. Med. Chem. 1996, 329, 475-482.
11. N. M. Carballeira, Prog. Lipid Res. 2002, 41, 437-456.
12. N. M. Carballeira, H. Cruz, N. L. Ayala, Lipids 2002, 37, 1033-1037.
13. N. M. Carballeira, M. Pagán, J. Nat. Prod. 2001, 64, 620-627.
14. J. N. Galgiani, Antimicrob. Agents Chemother. 1993, 37, 2517-2521.
15. Approved standard M27-A, Vol. 17, no.9, 1997 of the National Committee for Clinical Laboratory Standards, Wayne, PA, USA.